RELIEF THERAPEUTICS (Switzerland) Today

RLF -  Switzerland Stock  

CHF 0.23  0.02  8.00%

RELIEF THERAPEUTICS is selling for under 0.23 as of the 30th of July 2021; that is -8 percent decrease since the beginning of the trading day. The stock's lowest day price was 0.23. RELIEF THERAPEUTICS has a very high chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. Equity ratings for RELIEF THERAPEUTICS N are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 4th of August 2020 and ending today, the 30th of July 2021. Click here to learn more.
 Market Performance
4 of 100
  Odds Of Distress
Over 72
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

RELIEF THERAPEUTICS Stock Profile

Relief Therapeutics Holding AG, a biopharmaceutical company, provides patients with therapeutic relief from serious diseases with high unmet medical need. Relief Therapeutics Holding AG is based in Geneva, Switzerland. RELIEF THERAPEUTICS operates under Biotechnology classification in Switzerland and is traded on Switzerland Exchange. It employs 10 people. more on RELIEF THERAPEUTICS
RELIEF THERAPEUTICS has very high historical volatility over the last 90 days
RELIEF THERAPEUTICS has some characteristics of a very speculative penny stock
RELIEF THERAPEUTICS has high likelihood to experience some financial distress in the next 2 years
The company reported the revenue of 273 K. Net Loss for the year was (7.83 M) with loss before overhead, payroll, taxes, and interest of (68 K).
RELIEF THERAPEUTICS N has accumulated about 38.25 M in cash with (18.25 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.
Roughly 15.0% of the company outstanding shares are owned by corporate insiders
Legal NameRELIEF THERAPEUTICS N
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of RELIEF THERAPEUTICS's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Strong SellOvervalued
RELIEF THERAPEUTICS N (RLF) is traded on Switzerland Exchange in Switzerland and employs 10 people. The company currently falls under 'Small-Cap' category with current market capitalization of 628.05 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate RELIEF THERAPEUTICS's market, we take the total number of its shares issued and multiply it by RELIEF THERAPEUTICS's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. RELIEF THERAPEUTICS operates under Healthcare sector and is part of Biotechnology industry. The entity has 3.37 B outstanding shares. RELIEF THERAPEUTICS N has accumulated about 38.25 M in cash with (18.25 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.
Check RELIEF THERAPEUTICS Probability Of Bankruptcy
Ownership
RELIEF THERAPEUTICS owns a total of three billion three hundred seventy million outstanding shares. 30% of RELIEF THERAPEUTICS N outstanding shares are owned by third-party entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Therefore, institutional investors are subject to different rules and regulation than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or about to change. Please note that no matter how much assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.

Ownership Allocation (%)

Check RELIEF Ownership Details

RELIEF Stock Price Odds Analysis

What are RELIEF THERAPEUTICS's target price odds to finish over the current price? Depending on a normal probability distribution, the odds of RELIEF THERAPEUTICS jumping above the current price in 90 days from now is about 5.62%. The RELIEF THERAPEUTICS N probability density function shows the probability of RELIEF THERAPEUTICS stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon RELIEF THERAPEUTICS has a beta of 0.5599 indicating as returns on the market go up, RELIEF THERAPEUTICS average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding RELIEF THERAPEUTICS N will be expected to be much smaller as well. Additionally, the company has an alpha of 0.2762, implying that it can generate a 0.28 percent excess return over DOW after adjusting for the inherited market risk (beta).
 Odds Down 0.23HorizonTargetOdds Up 0.23 
94.33%90 days
 0.23 
5.62%
Based on a normal probability distribution, the odds of RELIEF THERAPEUTICS to move above the current price in 90 days from now is about 5.62 (This RELIEF THERAPEUTICS N probability density function shows the probability of RELIEF Stock to fall within a particular range of prices over 90 days) .

RELIEF THERAPEUTICS Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. RELIEF THERAPEUTICS market risk premium is the additional return an investor will receive from holding RELIEF THERAPEUTICS long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in RELIEF THERAPEUTICS. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although RELIEF THERAPEUTICS's alpha and beta are two of the key measurements used to evaluate RELIEF THERAPEUTICS's performance over the market, the standard measures of volatility play an important role as well.

RELIEF Stock Against Markets

Picking the right benchmark for RELIEF THERAPEUTICS stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in RELIEF THERAPEUTICS stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for RELIEF THERAPEUTICS is critical whether you are bullish or bearish towards RELIEF THERAPEUTICS N at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in RELIEF THERAPEUTICS without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Performance Analysis Now

   

Performance Analysis

Check effects of mean-variance optimization against your current asset allocation
All  Next Launch Module
Additionally, take a look at Your Equity Center. Note that the RELIEF THERAPEUTICS information on this page should be used as a complementary analysis to other RELIEF THERAPEUTICS's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Watchlist Optimization module to optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm.

Other Tools for RELIEF Stock

When running RELIEF THERAPEUTICS price analysis, check to measure RELIEF THERAPEUTICS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RELIEF THERAPEUTICS is operating at the current time. Most of RELIEF THERAPEUTICS's value examination focuses on studying past and present price action to predict the probability of RELIEF THERAPEUTICS's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move RELIEF THERAPEUTICS's price. Additionally, you may evaluate how the addition of RELIEF THERAPEUTICS to your portfolios can decrease your overall portfolio volatility.
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go